Understanding the Role of BEST3 Gene in Non-Small Cell Lung Cancer
Author Information
Author(s): Hanxiao Ren, Du Meng‐Ze, Liao Yulin, Zu Ruiling, Rao Lubei, Xiang Run, Zhang Xingmei, Liu Shan, Zhang Peiyin, Leng Ping, Qi Ling, Luo Huaichao
Primary Institution: Chengdu University of Traditional Chinese Medicine
Hypothesis
Genes associated with platelets may play a significant role in the precise subtyping of NSCLC patients.
Conclusion
The study identifies three platelet-related subtypes in NSCLC and highlights the potential of the BEST3 gene as a therapeutic target and prognostic marker.
Supporting Evidence
- BEST3 expression was validated by flow cytometry and functional assays.
- Overexpression of BEST3 in NSCLC cells suppressed apoptosis and promoted proliferation and migration.
- Three platelet-related subtypes were identified, with ten key prognostic genes including BEST3.
Takeaway
This study found that a gene called BEST3 is important for understanding a type of lung cancer and could help doctors predict how patients will do.
Methodology
The study used sequencing and clinical data from various databases, built a risk model based on genetic features, and validated findings through flow cytometry and functional assays.
Limitations
The study has a small sample size in FCM analysis and an incomplete understanding of BEST3's abnormal expression mechanisms.
Participant Demographics
The study included 402 platelet samples from NSCLC patients and 377 from healthy individuals.
Statistical Information
P-Value
7e−07
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website